| Home Market Dynamics You and Market Sector Analysis Company Insights AI Investing About Contact Us Login |
| The price action of Alnylam Pharmaceuticals (ALNY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The overall sentiment for Alnylam Pharmaceuticals is positive (overall 1.1, positive 2.1, negative -1) on 2025-10-31. The forces of Sentiment towards Fundamentals (2), Option Sentiment (1.5), Sector Price Trend (0.6), Market Risk Appetite (0.3), and Price Level Sentiment (0) will drive up the price. The forces of Stock Price Trend (-0.4), and Valuation Sentiment (-1.5) will drive down the price. 'Long' is the preferred trading strategy. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. |
| Date | Attention | Average Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Market Sentiment | Action | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-31 | 0% | 0% | 456.04 | 26 | 1.44% | -0.55% | -0.4 | 0.4 | Range | 2 | -1.5 |
| 2025-10-30 | 0% | 0% | 449.56 | 11 | -6.65% | -0.65% | 0.8 | 0.3 | Long | 0.8 | 1.5 |
| 2025-10-29 | 0% | 0% | 481.59 | 82 | 1.19% | 0.23% | 0.9 | 0.5 | Range | 1.3 | -1.5 |
| 2025-10-28 | 0% | 0% | 475.91 | 72 | -0.56% | 0.13% | 0.3 | 0.2 | Range | 0.1 | -1.5 |
| 2025-10-27 | 0% | 0% | 478.58 | 80 | 3.27% | 0.3% | -0.9 | -0.3 | Short | -1.9 | -1.5 |
| 2025-10-26 | 0% | 0% | -0 | -0.3 | Range | -1.8 | -1.5 | ||||
| 2025-10-25 | 0% | 0% | -0 | -0.3 | Range | -1.8 | -1.5 | ||||
| 2025-10-24 | 0% | 0% | 463.43 | 48 | -0.12% | 0.06% | -0 | -0.1 | Range | -1.8 | -1.5 |
| 2025-10-23 | 0% | 0% | 464 | 51 | -0.19% | 0.15% | 0 | -0.3 | Range | -1.1 | -1.5 |
| 2025-10-22 | 0% | 0% | 464.9 | 55 | -1.92% | 0.32% | -0.2 | -0.3 | Range | -0.7 | -1.5 |
| Trend sentiment reflects the price change, and market sentiment scores are calculated from many factors. Sentiment towards fundamentals and news sentiment are extracted from news headline. All sentiment scores are normalized in a -10 - +10 scale. | The price level reaches 100 at Bollinger upper band, and zero at lower band. | Range refers to range trade strategy. In an uptrend, the price will likely bullback after huge advance. As an investor, you may want to wait for the pullback to open long position. As a trader, you may consider tactical short. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. As a trader, you may consider tactical long. |
| 2025-10-31 17:09:17 As Amvuttra continues to outperform rival products, Alnylam is positioned strongly against competition in the market. |
| 2025-10-31 17:09:17 The company has a robust pipeline with multiple promising candidates that could contribute to future revenue growth and market expansion. |
| 2025-10-31 17:09:17 Alnylam's rising market cap and stock price reflect its strong market position, though some analysts express concerns over high valuation metrics. |
| 2025-10-31 17:09:17 The strong sales and market performance of Amvuttra have driven notable revenue growth, indicating successful product development and market acceptance. |
| 2025-10-31 17:09:17 Alnylam Pharmaceuticals reported impressive quarterly earnings, significantly exceeding market expectations, primarily due to the success of its product Amvuttra. |